1860 results
ABCDE of Primary ASCVD Prevention: Lifestyle Changes and Team-Based Care - Checklist
A – Antiplatelet Therapy
B –
ABCDE of Primary ASCVD ... #PrimaryCare #ASCVD ... Checklist #ABCs #ACCAHA
ABCDE of Primary Prevention: Lifestyle Changes and Team-Based Care - Checklist
A – Antiplatelet Therapy
B – Blood
#PrimaryCare #ASCVD ... Checklist #ABCs #ACCAHA
Diabetes Type 2 Medication Management and Titration Algorithm
- First line therapy is metformin and comprehensive lifestyle
and Titration Algorithm ... - Established ASCVD ... Without established ASCVD ... Medication #Management #Algorithm
ACC/AHA 2018 Cholesterol Guideline Algorithm for Secondary Prevention

#Cholesterol #Guidelines #Algorithm #ACCAHA #2018 #Cardiology #Statins #PCSK9
Cholesterol Guideline Algorithm ... Cholesterol #Guidelines #Algorithm ... #ACCAHA #2018 #
Mesenteric Ischemia - Differential Diagnostic Schema
Chronic: ASCVD, Venous, Vasculitides 5% (PAN, [E]GPA, IgA, MPA)
Acute
 - Venous
Schema Chronic: ASCVD ... hypo-/akinesis), ASCVD ... failure, Dissection, ASCVD ... Differential #Diagnosis #algorithm
Selected Clinical Trials of SGLT2 inhibitors in CVD and CKD
EMPA-REG OUTCOME - Empagliflozin lowered CV events
events in T2DM + ASCVD ... events in T2DM + ASCVD ... or ASCVD risk; ... MACE, in T2DM + ASCVD ... or ASCVD risk.
The recommended approach to the initiation of statin therapy in hyperlipidemia. 

Low-intensity:
-Lovastatin 20 mg
-Pravastatin 10-20 mg

Intermediate
cardiovasculardisease #diagnosis #algorithm ... atheroscleroticcardiovasculardisease #ascvd
Stages in the development of HF and recommended therapy by stage. ACEI indicates angiotensin-converting enzyme inhibitor;
Staging #Stages #ACCAHA ... #Algorithm #Management
AACE/ACE ASCVD Risk Factor Modifications Algorithm

#ASCVD #RiskFactor #Modifications #Algorithm #Management #AACE
AACE/ACE ASCVD Risk ... Modifications Algorithm ... #ASCVD #RiskFactor ... Modifications #Algorithm
The Evidence for Aspirin - Visual Abstract

Three new aspirin trials in three different populations: 
 -
Moderate Risk (ASCVD